{"product_id":"mayo-clinics-9th-annual-hematology-oncology-case-based-approaches","title":"Mayo Clinic’s 9th Annual Hematology\/Oncology Case-Based Approaches to Patient Care for Advanced Practice Providers and Nurses 2026","description":"\u003cdiv class=\"\" data-turn-id-container=\"77811c7d-9b42-473f-8780-43461cbc1457\" data-is-intersecting=\"true\"\u003e\r\n\u003cdiv class=\"relative w-full overflow-visible\"\u003e\n\u003csection class=\"text-token-text-primary w-full focus:outline-none has-data-writing-block:pointer-events-none [\u0026amp;:has([data-writing-block])\u0026gt;*]:pointer-events-auto R6Vx5W_threadScrollVars scroll-mb-[calc(var(--scroll-root-safe-area-inset-bottom,0px)+var(--thread-response-height))] scroll-mt-(--header-height)\" dir=\"auto\" data-turn-id=\"77811c7d-9b42-473f-8780-43461cbc1457\" data-turn-id-container=\"77811c7d-9b42-473f-8780-43461cbc1457\" data-testid=\"conversation-turn-399\" data-scroll-anchor=\"false\" data-turn=\"user\"\u003e\u003c\/section\u003e\r\n\u003cdiv class=\"contents\"\u003e\r\n\u003ch1 data-section-id=\"1hzovu0\" data-start=\"0\" data-end=\"132\"\u003eMayo Clinic’s 9th Annual Hematology\/Oncology Case-Based Approaches to Patient Care for Advanced Practice Providers and Nurses 2026Mayo Clinic’s 9th Annual Hematology\/Oncology Case-Based Approaches to Patient Care for Advanced Practice Providers and Nurses 2026\u003c\/h1\u003e\r\n\u003ch2 data-section-id=\"1nvjcfi\" data-start=\"134\" data-end=\"232\"\u003ePractical Case-Based Hematology \u0026amp; Oncology Education for Advanced Practice Providers and Nurses\u003c\/h2\u003e\r\n\u003cp data-start=\"234\" data-end=\"810\"\u003eThe \u003cstrong data-start=\"238\" data-end=\"372\"\u003eMayo Clinic’s 9th Annual Hematology\/Oncology Case-Based Approaches to Patient Care for Advanced Practice Providers and Nurses 2026\u003c\/strong\u003e is a comprehensive educational program designed to enhance the clinical knowledge and decision-making skills of healthcare professionals caring for patients with hematologic and oncologic malignancies. Through a highly interactive, case-based learning format, participants gain practical strategies for diagnosis, treatment selection, supportive care, and management of treatment-related complications across a broad spectrum of cancers.\u003c\/p\u003e\r\n\u003cp data-start=\"812\" data-end=\"1043\"\u003eFeaturing \u003cstrong data-start=\"822\" data-end=\"856\"\u003eLive Recording Videos and PDFs\u003c\/strong\u003e, this program delivers evidence-based updates and real-world clinical insights from Mayo Clinic experts, helping clinicians navigate the rapidly evolving landscape of modern cancer care.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"1045\" data-end=\"1048\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1sp67mj\" data-start=\"1050\" data-end=\"1068\"\u003eCourse Overview\u003c\/h2\u003e\r\n\u003cp data-start=\"1070\" data-end=\"1405\"\u003eCancer treatment continues to advance rapidly with the introduction of novel immunotherapies, targeted agents, cellular therapies, and personalized treatment approaches. Advanced practice providers and nurses play a critical role in patient education, treatment monitoring, toxicity management, and multidisciplinary care coordination.\u003c\/p\u003e\r\n\u003cp data-start=\"1407\" data-end=\"1656\"\u003eThis course focuses on practical clinical scenarios commonly encountered in oncology practice, helping participants improve patient outcomes through evidence-based treatment decisions, supportive care strategies, and interdisciplinary collaboration.\u003c\/p\u003e\r\n\u003cp data-start=\"1658\" data-end=\"1827\"\u003eUsing a case-based approach, faculty guide learners through complex patient presentations, treatment planning, adverse event management, and survivorship considerations.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"1829\" data-end=\"1832\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1scsphp\" data-start=\"1834\" data-end=\"1856\"\u003eLearning Objectives\u003c\/h2\u003e\r\n\u003cp data-start=\"1858\" data-end=\"1921\"\u003eUpon completion of this activity, participants will be able to:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"1923\" data-end=\"2734\"\u003e\r\n \t\u003cli data-section-id=\"1s3jonp\" data-start=\"1923\" data-end=\"2016\"\u003eDifferentiate between immunotherapy, targeted therapy, chemotherapy, and radiation therapy.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1mslu4v\" data-start=\"2017\" data-end=\"2117\"\u003eSelect appropriate treatment strategies based on cancer type, stage, and patient-specific factors.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1yt2hiy\" data-start=\"2118\" data-end=\"2208\"\u003eApply current evidence-based recommendations for hematologic and oncologic malignancies.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"111nsl1\" data-start=\"2209\" data-end=\"2270\"\u003eAssess patient eligibility for bone marrow transplantation.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"jnbuj6\" data-start=\"2271\" data-end=\"2342\"\u003eEvaluate indications and clinical applications of CAR T-cell therapy.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1hdh9eo\" data-start=\"2343\" data-end=\"2436\"\u003eIncorporate supportive and palliative care principles into comprehensive cancer management.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1toxt7\" data-start=\"2437\" data-end=\"2500\"\u003eRecognize common toxicities associated with cancer therapies.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1e464f7\" data-start=\"2501\" data-end=\"2588\"\u003eImplement evidence-based management strategies for treatment-related adverse effects.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"s7kt4e\" data-start=\"2589\" data-end=\"2663\"\u003eImprove interdisciplinary communication and collaborative oncology care.\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"aaqmw7\" data-start=\"2664\" data-end=\"2734\"\u003eEnhance clinical decision-making through case-based problem solving.\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"2736\" data-end=\"2739\"\u003e\r\n\r\n\u003ch2 data-section-id=\"hvj5zg\" data-start=\"2741\" data-end=\"2762\"\u003eKey Topics Covered\u003c\/h2\u003e\r\n\u003ch3 data-section-id=\"1g8vigx\" data-start=\"2764\" data-end=\"2792\"\u003eHematologic Malignancies\u003c\/h3\u003e\r\n\u003cp data-start=\"2794\" data-end=\"2814\"\u003eParticipants review:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"2816\" data-end=\"2947\"\u003e\r\n \t\u003cli data-section-id=\"qqn33z\" data-start=\"2816\" data-end=\"2826\"\u003eLeukemia\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"z9brkb\" data-start=\"2827\" data-end=\"2837\"\u003eLymphoma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"isftza\" data-start=\"2838\" data-end=\"2856\"\u003eMultiple myeloma\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"5nt3eh\" data-start=\"2857\" data-end=\"2890\"\u003eMyelodysplastic syndromes (MDS)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1w66to9\" data-start=\"2891\" data-end=\"2914\"\u003eBone marrow disorders\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17bfq9\" data-start=\"2915\" data-end=\"2947\"\u003eEmerging hematologic therapies\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"2949\" data-end=\"3030\"\u003eFaculty discuss contemporary treatment strategies and evolving standards of care.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"3032\" data-end=\"3035\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1725qai\" data-start=\"3037\" data-end=\"3061\"\u003eSolid Tumor Oncology\u003c\/h3\u003e\r\n\u003cp data-start=\"3063\" data-end=\"3081\"\u003eCoverage includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"3083\" data-end=\"3232\"\u003e\r\n \t\u003cli data-section-id=\"1ozu8ai\" data-start=\"3083\" data-end=\"3104\"\u003eCommon solid tumors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ocmowc\" data-start=\"3105\" data-end=\"3126\"\u003eTreatment selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"7phdgl\" data-start=\"3127\" data-end=\"3144\"\u003eDisease staging\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"17kr4lz\" data-start=\"3145\" data-end=\"3175\"\u003eMultidisciplinary management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"dzjvkr\" data-start=\"3176\" data-end=\"3209\"\u003ePersonalized treatment planning\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1idt30t\" data-start=\"3210\" data-end=\"3232\"\u003eLong-term monitoring\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3234\" data-end=\"3311\"\u003eParticipants gain practical approaches to managing complex oncology patients.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"3313\" data-end=\"3316\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1fi2gl4\" data-start=\"3318\" data-end=\"3335\"\u003eImmunotherapy\u003c\/h3\u003e\r\n\u003cp data-start=\"3337\" data-end=\"3352\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"3354\" data-end=\"3506\"\u003e\r\n \t\u003cli data-section-id=\"1tpfdya\" data-start=\"3354\" data-end=\"3384\"\u003eImmune checkpoint inhibitors\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"bmc0on\" data-start=\"3385\" data-end=\"3407\"\u003eMechanisms of action\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v51imz\" data-start=\"3408\" data-end=\"3427\"\u003ePatient selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"30wr2o\" data-start=\"3428\" data-end=\"3459\"\u003eImmune-related adverse events\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ui9oua\" data-start=\"3460\" data-end=\"3482\"\u003eToxicity recognition\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ktxz7r\" data-start=\"3483\" data-end=\"3506\"\u003eManagement algorithms\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3508\" data-end=\"3591\"\u003eSpecial emphasis is placed on real-world management of immunotherapy complications.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"3593\" data-end=\"3596\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1oldp1\" data-start=\"3598\" data-end=\"3618\"\u003eTargeted Therapy\u003c\/h3\u003e\r\n\u003cp data-start=\"3620\" data-end=\"3638\"\u003eSessions focus on:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"3640\" data-end=\"3792\"\u003e\r\n \t\u003cli data-section-id=\"i2vh88\" data-start=\"3640\" data-end=\"3673\"\u003eMolecularly targeted treatments\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ci6ij2\" data-start=\"3674\" data-end=\"3694\"\u003ePrecision oncology\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1g98x50\" data-start=\"3695\" data-end=\"3723\"\u003eBiomarker-driven therapies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"uolvfk\" data-start=\"3724\" data-end=\"3746\"\u003eTreatment monitoring\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"p8m6g3\" data-start=\"3747\" data-end=\"3770\"\u003eResistance mechanisms\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"4iy106\" data-start=\"3771\" data-end=\"3792\"\u003eToxicity management\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"3794\" data-end=\"3875\"\u003eParticipants learn how targeted therapies are integrated into modern cancer care.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"3877\" data-end=\"3880\"\u003e\r\n\r\n\u003ch3 data-section-id=\"omaw8f\" data-start=\"3882\" data-end=\"3918\"\u003eChemotherapy \u0026amp; Radiation Therapy\u003c\/h3\u003e\r\n\u003cp data-start=\"3920\" data-end=\"3938\"\u003eCoverage includes:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"3940\" data-end=\"4130\"\u003e\r\n \t\u003cli data-section-id=\"6wezcc\" data-start=\"3940\" data-end=\"3978\"\u003eConventional chemotherapy principles\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"15tguxb\" data-start=\"3979\" data-end=\"4011\"\u003eRadiation treatment approaches\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ch99li\" data-start=\"4012\" data-end=\"4034\"\u003eTreatment sequencing\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v992pb\" data-start=\"4035\" data-end=\"4067\"\u003eCombination therapy strategies\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"anzxha\" data-start=\"4068\" data-end=\"4095\"\u003eAdverse effect management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"v3cbv8\" data-start=\"4096\" data-end=\"4130\"\u003ePatient education considerations\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4132\" data-end=\"4204\"\u003eThe course reviews practical considerations for daily oncology practice.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"4206\" data-end=\"4209\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1q5as5w\" data-start=\"4211\" data-end=\"4242\"\u003eBone Marrow Transplantation\u003c\/h3\u003e\r\n\u003cp data-start=\"4244\" data-end=\"4259\"\u003eTopics include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4261\" data-end=\"4432\"\u003e\r\n \t\u003cli data-section-id=\"vyr04\" data-start=\"4261\" data-end=\"4294\"\u003eIndications for transplantation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ckb8kg\" data-start=\"4295\" data-end=\"4327\"\u003ePatient eligibility assessment\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"qaxnt\" data-start=\"4328\" data-end=\"4355\"\u003ePre-transplant evaluation\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"6i55l8\" data-start=\"4356\" data-end=\"4384\"\u003ePost-transplant monitoring\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"4hrv5\" data-start=\"4385\" data-end=\"4410\"\u003eComplication management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"wgsct4\" data-start=\"4411\" data-end=\"4432\"\u003eLong-term follow-up\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4434\" data-end=\"4521\"\u003eParticipants gain a better understanding of transplant referral and patient management.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"4523\" data-end=\"4526\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1o7pqve\" data-start=\"4528\" data-end=\"4550\"\u003eCAR T-Cell Therapy\u003c\/h3\u003e\r\n\u003cp data-start=\"4552\" data-end=\"4569\"\u003eSessions address:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4571\" data-end=\"4727\"\u003e\r\n \t\u003cli data-section-id=\"1wonui6\" data-start=\"4571\" data-end=\"4608\"\u003eCellular immunotherapy fundamentals\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1v51imz\" data-start=\"4609\" data-end=\"4628\"\u003ePatient selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"mmgi8t\" data-start=\"4629\" data-end=\"4649\"\u003eTreatment pathways\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ay6i8v\" data-start=\"4650\" data-end=\"4683\"\u003eCytokine release syndrome (CRS)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"o443qt\" data-start=\"4684\" data-end=\"4710\"\u003eNeurotoxicity management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"8cpd9g\" data-start=\"4711\" data-end=\"4727\"\u003eFollow-up care\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"4729\" data-end=\"4814\"\u003eFaculty discuss the expanding role of CAR T-cell therapy in hematologic malignancies.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"4816\" data-end=\"4819\"\u003e\r\n\r\n\u003ch3 data-section-id=\"evscuv\" data-start=\"4821\" data-end=\"4853\"\u003eSupportive \u0026amp; Palliative Care\u003c\/h3\u003e\r\n\u003cp data-start=\"4855\" data-end=\"4874\"\u003eKey topics include:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"4876\" data-end=\"5012\"\u003e\r\n \t\u003cli data-section-id=\"j92h5m\" data-start=\"4876\" data-end=\"4896\"\u003eSymptom management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ipdwsf\" data-start=\"4897\" data-end=\"4921\"\u003eCancer-related fatigue\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"s3qbe5\" data-start=\"4922\" data-end=\"4939\"\u003ePain management\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"55x15u\" data-start=\"4940\" data-end=\"4961\"\u003eNutritional support\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"abu9o8\" data-start=\"4962\" data-end=\"4981\"\u003ePsychosocial care\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"xjh50r\" data-start=\"4982\" data-end=\"5012\"\u003eQuality-of-life optimization\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\u003cp data-start=\"5014\" data-end=\"5098\"\u003eThe course emphasizes patient-centered cancer care throughout the disease continuum.\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"5100\" data-end=\"5103\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1f0rq0s\" data-start=\"5105\" data-end=\"5138\"\u003eTreatment Toxicity Management\u003c\/h3\u003e\r\n\u003cp data-start=\"5140\" data-end=\"5160\"\u003eParticipants review:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5162\" data-end=\"5362\"\u003e\r\n \t\u003cli data-section-id=\"rs2eyn\" data-start=\"5162\" data-end=\"5196\"\u003eImmunotherapy-related toxicities\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"l1se7y\" data-start=\"5197\" data-end=\"5225\"\u003eChemotherapy complications\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1dddmlp\" data-start=\"5226\" data-end=\"5260\"\u003eTargeted therapy adverse effects\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"v95oeo\" data-start=\"5261\" data-end=\"5294\"\u003eRadiation-related complications\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"msbya7\" data-start=\"5295\" data-end=\"5331\"\u003eSupportive treatment interventions\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1a2z49n\" data-start=\"5332\" data-end=\"5362\"\u003eClinical practice guidelines\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5364\" data-end=\"5367\"\u003e\r\n\r\n\u003ch3 data-section-id=\"1yqi8ye\" data-start=\"5369\" data-end=\"5408\"\u003eCase-Based Clinical Decision Making\u003c\/h3\u003e\r\n\u003cp data-start=\"5410\" data-end=\"5456\"\u003eThrough interactive cases, participants learn:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"5458\" data-end=\"5620\"\u003e\r\n \t\u003cli data-section-id=\"15vmj1n\" data-start=\"5458\" data-end=\"5480\"\u003eDiagnostic reasoning\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"ocmowc\" data-start=\"5481\" data-end=\"5502\"\u003eTreatment selection\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1gaikwb\" data-start=\"5503\" data-end=\"5535\"\u003eMultidisciplinary coordination\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1z0j927\" data-start=\"5536\" data-end=\"5578\"\u003eManagement of complex oncology scenarios\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1vwya05\" data-start=\"5579\" data-end=\"5620\"\u003eEvidence-based clinical problem solving\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"5622\" data-end=\"5625\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1cq7b5x\" data-start=\"5627\" data-end=\"5650\"\u003eEducational Features\u003c\/h2\u003e\r\n\u003cp data-start=\"5652\" data-end=\"5680\"\u003e✔ Case-Based Learning Format\u003c\/p\u003e\r\n\u003cp data-start=\"5682\" data-end=\"5703\"\u003e✔ Mayo Clinic Faculty\u003c\/p\u003e\r\n\u003cp data-start=\"5705\" data-end=\"5733\"\u003e✔ Practical Oncology Updates\u003c\/p\u003e\r\n\u003cp data-start=\"5735\" data-end=\"5766\"\u003e✔ Real-World Clinical Scenarios\u003c\/p\u003e\r\n\u003cp data-start=\"5768\" data-end=\"5805\"\u003e✔ Evidence-Based Treatment Strategies\u003c\/p\u003e\r\n\u003cp data-start=\"5807\" data-end=\"5838\"\u003e✔ Immunotherapy \u0026amp; CAR T Updates\u003c\/p\u003e\r\n\u003cp data-start=\"5840\" data-end=\"5869\"\u003e✔ Supportive Care Integration\u003c\/p\u003e\r\n\u003cp data-start=\"5871\" data-end=\"5908\"\u003e✔ Multidisciplinary Cancer Management\u003c\/p\u003e\r\n\u003cp data-start=\"5910\" data-end=\"5944\"\u003e✔ Advanced Practice Provider Focus\u003c\/p\u003e\r\n\u003cp data-start=\"5946\" data-end=\"5978\"\u003e✔ Immediate Clinical Application\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"5980\" data-end=\"5983\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1m9xcqo\" data-start=\"5985\" data-end=\"6003\"\u003eTarget Audience\u003c\/h2\u003e\r\n\u003cp data-start=\"6005\" data-end=\"6030\"\u003eThis course is ideal for:\u003c\/p\u003e\r\n\r\n\u003cul data-start=\"6032\" data-end=\"6273\"\u003e\r\n \t\u003cli data-section-id=\"b0y95q\" data-start=\"6032\" data-end=\"6059\"\u003eNurse Practitioners (NPs)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1gfr302\" data-start=\"6060\" data-end=\"6088\"\u003ePhysician Assistants (PAs)\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1cl7ez8\" data-start=\"6089\" data-end=\"6106\"\u003eOncology Nurses\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1wwyzb7\" data-start=\"6107\" data-end=\"6126\"\u003eHematology Nurses\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1na03fb\" data-start=\"6127\" data-end=\"6148\"\u003eMedical Oncologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"rxqb2j\" data-start=\"6149\" data-end=\"6164\"\u003eHematologists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1vdecm\" data-start=\"6165\" data-end=\"6195\"\u003eInternal Medicine Physicians\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"droiy9\" data-start=\"6196\" data-end=\"6209\"\u003ePharmacists\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"1ybrjqb\" data-start=\"6210\" data-end=\"6231\"\u003eResidents \u0026amp; Fellows\u003c\/li\u003e\r\n \t\u003cli data-section-id=\"9zoqug\" data-start=\"6232\" data-end=\"6273\"\u003eAdvanced Practice Providers in Oncology\u003c\/li\u003e\r\n\u003c\/ul\u003e\r\n\r\n\u003chr data-start=\"6275\" data-end=\"6278\"\u003e\r\n\r\n\u003ch2 data-section-id=\"8w266h\" data-start=\"6280\" data-end=\"6309\"\u003eWhy This Course Stands Out\u003c\/h2\u003e\r\n\u003cp data-start=\"6311\" data-end=\"6377\"\u003e✔ Specifically designed for advanced practice providers and nurses\u003c\/p\u003e\r\n\u003cp data-start=\"6379\" data-end=\"6428\"\u003e✔ Strong emphasis on practical patient management\u003c\/p\u003e\r\n\u003cp data-start=\"6430\" data-end=\"6486\"\u003e✔ Comprehensive review of hematology and oncology topics\u003c\/p\u003e\r\n\u003cp data-start=\"6488\" data-end=\"6547\"\u003e✔ Detailed coverage of immunotherapy and CAR T-cell therapy\u003c\/p\u003e\r\n\u003cp data-start=\"6549\" data-end=\"6597\"\u003e✔ Focus on treatment-related toxicity management\u003c\/p\u003e\r\n\u003cp data-start=\"6599\" data-end=\"6639\"\u003e✔ Interactive case-based teaching format\u003c\/p\u003e\r\n\u003cp data-start=\"6641\" data-end=\"6682\"\u003e✔ Evidence-based clinical recommendations\u003c\/p\u003e\r\n\u003cp data-start=\"6684\" data-end=\"6727\"\u003e✔ Emphasis on multidisciplinary cancer care\u003c\/p\u003e\r\n\u003cp data-start=\"6729\" data-end=\"6792\"\u003e✔ Applicable to both inpatient and outpatient oncology practice\u003c\/p\u003e\r\n\u003cp data-start=\"6794\" data-end=\"6831\"\u003e✔ Led by Mayo Clinic oncology experts\u003c\/p\u003e\r\n\r\n\r\n\u003chr data-start=\"6833\" data-end=\"6836\"\u003e\r\n\r\n\u003ch2 data-section-id=\"1hsm8m9\" data-start=\"6838\" data-end=\"6855\"\u003eClinical Value\u003c\/h2\u003e\r\n\u003cp data-start=\"6857\" data-end=\"7372\"\u003eThe \u003cstrong data-start=\"6861\" data-end=\"6995\"\u003eMayo Clinic’s 9th Annual Hematology\/Oncology Case-Based Approaches to Patient Care for Advanced Practice Providers and Nurses 2026\u003c\/strong\u003e provides a practical and comprehensive review of modern cancer care. Covering hematologic malignancies, solid tumors, immunotherapy, targeted therapy, chemotherapy, radiation therapy, bone marrow transplantation, CAR T-cell therapy, and supportive care, this program equips clinicians with the knowledge and skills needed to deliver high-quality, evidence-based oncology care.\u003c\/p\u003e\r\n\r\n\u003cdiv class=\"group-learning-objectives field-group-div\"\u003e\r\n\u003cdiv class=\"field field-name-field-learning-objectives field-type-text-long field-label-hidden\"\u003e\r\n\u003cdiv class=\"field-items\"\u003e\r\n\u003cdiv class=\"field-item even\"\u003e\r\n\u003ctable class=\"Table\"\u003e\r\n\u003ctbody\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cstrong\u003eDay 1\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eThursday, April 9, 2026\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eRegistration Opens, Exhibits and Lunch\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e12:15 PM\u003c\/td\u003e\r\n\u003ctd\u003eWelcome\/Introduction\r\nModerator: Ashton Boyle, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:15 PM\u003c\/td\u003e\r\n\u003ctd\u003e12:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eDo we matter in Cancer Care? – The financial, social, and emotional impacts of APPs\r\nStephanie Gebhardt, ARNP\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:45 PM\u003c\/td\u003e\r\n\u003ctd\u003e1:15 PM\u003c\/td\u003e\r\n\u003ctd\u003eThe Difference a Year Can Make: A Case Study of  Cholangiocarcinoma\r\nMicah Weber, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1:15 PM\u003c\/td\u003e\r\n\u003ctd\u003e1:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eLiver transplant as an option for metastatic colon cancer\r\nSamantha Inabinett, APRN\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1:45 PM\u003c\/td\u003e\r\n\u003ctd\u003e2:15 PM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2:15 PM\u003c\/td\u003e\r\n\u003ctd\u003e2:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eBreak and Exhibits\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2:45 PM\u003c\/td\u003e\r\n\u003ctd\u003e3:15 PM\u003c\/td\u003e\r\n\u003ctd\u003eUnusual plasma cell malignancies\r\nTaimur Sher, MBBS, MD\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e3:15 PM\u003c\/td\u003e\r\n\u003ctd\u003e3:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eCancer-Associated Thrombosis\r\nJordan Davis, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e3:45 PM\u003c\/td\u003e\r\n\u003ctd\u003e4:15 PM\u003c\/td\u003e\r\n\u003ctd\u003eLong-Term Impacts of T-Cell Engaging Therapies: Case Insights and Clinical Considerations\r\nMegan Melody, MD, Tampa General Hospital\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e4:15 PM\u003c\/td\u003e\r\n\u003ctd\u003e4:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e4:45 PM\u003c\/td\u003e\r\n\u003ctd\u003e4:45 PM\u003c\/td\u003e\r\n\u003ctd\u003eAdjourn\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e5:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e6:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eWelcome Reception\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cstrong\u003eDay 2\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eFriday, April 10, 2026\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e7:55 AM\u003c\/td\u003e\r\n\u003ctd\u003eBreakfast and Exhibits\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7:55 AM\u003c\/td\u003e\r\n\u003ctd\u003e8:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eIntroduction\r\nModerator: Nicole Gannon, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e8:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eChronic GVHD in the Real World: Practical Case Discussions for APPs and Nurses\r\nKatelyn Keller, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e9:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eOh My Blast – What to do if you suspect acute leukemia\r\nAshley Westberry, APRN\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e9:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eA new Era in Myeloma: Case-Based Perspectives on Bispecific Antibodies\r\nAndre J. Fernandez, MPAS, P.A.-C. and Caitie J. Flott, APRN, M.S.N.\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e9:45 AM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9:45 AM\u003c\/td\u003e\r\n\u003ctd\u003e10:15 AM\u003c\/td\u003e\r\n\u003ctd\u003eBreak and Exhibits\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10:15 AM\u003c\/td\u003e\r\n\u003ctd\u003e10:45 AM\u003c\/td\u003e\r\n\u003ctd\u003eNovel Therapeutics in Melanoma\r\nLindsey Noland, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10:45 AM\u003c\/td\u003e\r\n\u003ctd\u003e11:15 AM\u003c\/td\u003e\r\n\u003ctd\u003eImmunotherapy toxicities\r\nEmily Kelbert, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11:15 AM\u003c\/td\u003e\r\n\u003ctd\u003e11:45 AM\u003c\/td\u003e\r\n\u003ctd\u003eThe Zebra Cancer: Case Based Approach to the Management of Neuroendocrine Tumors\r\nRachel Eiring, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11:45 AM\u003c\/td\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e1:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eLunch, Exhibits \u0026amp; Abstract Session\r\nWinston Tan, MD\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e1:30 PM\u003c\/td\u003e\r\n\u003ctd\u003eCancer Pain Management\r\nChimere Bruning, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e1:30 PM\u003c\/td\u003e\r\n\u003ctd\u003e2:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eContinuity, Coordination and Connection: Safe Transitions after Bone Marrow Transplant\r\nErin Taylor, RN and Nicole Gannon, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e2:30 PM\u003c\/td\u003e\r\n\u003ctd\u003eExpecting the Unexpected: Managing Reactions in the Infusion Center\r\nAlex Fein, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e2:30 PM\u003c\/td\u003e\r\n\u003ctd\u003e3:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e3:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e3:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eAdjourn\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003ctd\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e\u003cstrong\u003eDay 3\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003ctd colspan=\"2\"\u003e\u003cstrong\u003eSaturday, April 11, 2026\u003c\/strong\u003e\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e7:55 AM\u003c\/td\u003e\r\n\u003ctd\u003eBreakfast and Exhibits\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e7:55 AM\u003c\/td\u003e\r\n\u003ctd\u003e8:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eIntroduction\r\nModerator: Katie Keller, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e8:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eBad Medicine: Talking with Patients about Ivermectin and other Low Evidence Treatments\r\nKate McLaughlin, APRN\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e8:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e9:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eManaging Cardiovascular Complications of Cancer Therapy: Insights from Clinical Cases\r\nAlyssa McPherson, APRN\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e9:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eCellular Therapies for Autoimmune Disease\r\nErnesto Ayala, M.D.\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e9:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e10:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e10:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eBreak and Exhibits\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e10:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e11:00 AM\u003c\/td\u003e\r\n\u003ctd\u003eOral Chemotherapy\r\nMorgan Leavins, Pharm.D., R.Ph.\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11:00 AM\u003c\/td\u003e\r\n\u003ctd\u003e11:30 AM\u003c\/td\u003e\r\n\u003ctd\u003eApproach to GI Malignancies in the Hospital\r\nJeremy Jones, MD\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e11:30 AM\u003c\/td\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003eLessons Learned: The Stresses and Successes of a Long-Term Hem\/Onc APP Career\r\nNicole Gannon, PA-C\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:00 PM\u003c\/td\u003e\r\n\u003ctd\u003e12:30 PM\u003c\/td\u003e\r\n\u003ctd\u003eQ\u0026amp;A Panel\r\nAll Presenting Faculty\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:30 PM\u003c\/td\u003e\r\n\u003ctd\u003e12:40 PM\u003c\/td\u003e\r\n\u003ctd\u003eClosing Remarks\/Post Test\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003ctr\u003e\r\n\u003ctd\u003e12:40 PM\u003c\/td\u003e\r\n\u003ctd\u003e12:40 PM\u003c\/td\u003e\r\n\u003ctd\u003eAdjourn\u003c\/td\u003e\r\n\u003c\/tr\u003e\r\n\u003c\/tbody\u003e\r\n\u003c\/table\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e\r\n\u003c\/div\u003e","brand":"Meducourse","offers":[{"title":"Default Title","offer_id":43066691911778,"sku":"MED-AMB09448","price":180.0,"currency_code":"USD","in_stock":true}],"thumbnail_url":"\/\/cdn.shopify.com\/s\/files\/1\/0662\/9549\/6802\/files\/Mayo-Clinics-9th-Annual-HematologyOncology-Case-Based-Approaches-to-Patient-Care-for-Advanced-Practice-Providers-and-Nurses-2026.jpg?v=1782499385","url":"https:\/\/meducourse.com\/products\/mayo-clinics-9th-annual-hematology-oncology-case-based-approaches","provider":"Meducourse","version":"1.0","type":"link"}